159 related articles for article (PubMed ID: 10342749)
1. Endogenous neutralizing anti-IL-1 alpha autoantibodies in inflammatory skin diseases: possible natural inhibitor for over expressed epidermal IL-1.
Mizutani H; Ohmoto Y; Kupper TS; Shimizu M
J Dermatol Sci; 1998 May; 20(1):63-71. PubMed ID: 10342749
[TBL] [Abstract][Full Text] [Related]
2. Role of B cells in immune-mediated dermatoses.
Wang WM; Guo L; Jin HZ
Mol Immunol; 2020 Oct; 126():95-100. PubMed ID: 32795664
[TBL] [Abstract][Full Text] [Related]
3. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
4. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
5. Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris.
Schinner J; Cunha T; Mayer JU; Hörster S; Kind P; Didona D; Keber C; Hertl M; Worzfeld T; Juratli HA
Front Immunol; 2023; 14():1203776. PubMed ID: 37415985
[TBL] [Abstract][Full Text] [Related]
6. [Autoimmune bullous skin diseases].
Joly P
Rev Med Interne; 1999 Jan; 20(1):26-38. PubMed ID: 10220817
[TBL] [Abstract][Full Text] [Related]
7. Human amnion membrane as a substrate for the detection of autoantibodies in pemphigus vulgaris and bullous pemphigoid.
Sezin T; Avitan-Hersh E; Indelman M; Moscona R; Sabo E; Katz R; Pollack S; Bergman R
Isr Med Assoc J; 2014 Apr; 16(4):217-23. PubMed ID: 24834757
[TBL] [Abstract][Full Text] [Related]
8. High-titer interferon-alpha antibodies in a patient with pemphigus foliaceus.
Prümmer O; Zillikens D; Porzsolt F
Exp Dermatol; 1996 Aug; 5(4):213-7. PubMed ID: 8889468
[TBL] [Abstract][Full Text] [Related]
9. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production.
Bhol KC; Desai A; Kumari S; Colon JE; Ahmed AR
Clin Immunol; 2001 Aug; 100(2):172-80. PubMed ID: 11465946
[TBL] [Abstract][Full Text] [Related]
10. Effect of nonenzymatic glycosylation on the titers of circulating autoantibodies in pemphigus and pemphigoid.
Nakagawa A; Kobayashi N; Yamashina Y; Nakatani C; Muramatsu T; Mori T; Shirai T
J Dermatol; 1998 Nov; 25(11):710-5. PubMed ID: 9863283
[TBL] [Abstract][Full Text] [Related]
11. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
Brooks WS; Lee YY; Abell E; Deng JS
J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
[TBL] [Abstract][Full Text] [Related]
12. Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen).
Hsu S; Ghohestani RF; Uitto J
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):136-41. PubMed ID: 10607335
[TBL] [Abstract][Full Text] [Related]
13. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
Bhol KC; Rojas AI; Khan IU; Ahmed AR
Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
[TBL] [Abstract][Full Text] [Related]
14. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
[TBL] [Abstract][Full Text] [Related]
15. An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases.
Terui T; Hirao T; Sato Y; Uesugi T; Honda M; Iguchi M; Matsumura N; Kudoh K; Aiba S; Tagami H
Exp Dermatol; 1998 Dec; 7(6):327-34. PubMed ID: 9858135
[TBL] [Abstract][Full Text] [Related]
16. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
Kapp A; Neuner P; Krutmann J; Luger TA; Schöpf E
Acta Derm Venereol; 1991; 71(5):403-6. PubMed ID: 1684468
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-intercellular cement substance and anti-basement membrane zone antibodies by radioimmunoassay using SCaBER tumour cell line as substrate.
Bevan HJ; Murahata RI; Ahmed AR
Br J Dermatol; 1983 Sep; 109(3):261-5. PubMed ID: 6351893
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
Mouquet H; Drenovska K; Lartigue A; Joly P; Drouot L; Thomas M; Tron F; Gilbert D
Clin Immunol; 2008 Nov; 129(2):304-12. PubMed ID: 18790674
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D
J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitor.
Garrone P; Djossou O; Fossiez F; Reyes J; Ait-Yahia S; Maat C; Ho S; Hauser T; Dayer JM; Greffe J; Miossec P; Lebecque S; Rousset F; Banchereau J
Mol Immunol; 1996; 33(7-8):649-58. PubMed ID: 8760277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
